Analyst Price Targets — BTMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 16, 2026 12:14 pm | Les Sulewski | Truist Financial | $4.00 | $2.01 | TheFly | Biote price target lowered to $4 from $5 at Truist |
| March 12, 2026 1:29 pm | — | National Bank | $2.50 | $1.58 | StreetInsider | biote Corp. (BTMD) PT Lowered to $2.50 at TD Cowen |
| January 7, 2026 12:20 pm | — | Truist Financial | $5.00 | $2.54 | TheFly | Biote price target lowered to $5 from $6 at Truist |
| June 21, 2024 6:37 am | Gregory Fraser | Truist Financial | $9.00 | $7.23 | StreetInsider | Truist Securities Reiterates Buy Rating on biote Corp. (BTMD) |
| March 13, 2024 5:46 am | Kaumil Gajrawala | Jefferies | $8.24 | $6.09 | StreetInsider | biote Corp. (BTMD) PT Raised to $8.24 at Jefferies |
Latest News for BTMD
biote Corp. (BTMD) Q2 2026 Earnings Call Transcript
biote Corp. (BTMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.1 per share a year ago.
biote NASDAQ: BTMD reported lower second-quarter revenue and a net loss as a voluntary recall of certain hormone pellets supplied by Asteria Health disrupted procedure volumes, while management said supply conditions have since normalized and should support sequential improvement in the second half of 2026.
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced financial results for the second quarter ended June 30, 2026. “Over the past year Biote has achieved meaningful progress in advancing our strategic initiatives, driving fundamental improvements that we believe…
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners' patients, today announced the Company will provide second quarter financial results on Wednesday, August 5, 2026, after the close of the market. A conference call to discuss the firm's results will be held at…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BTMD.
U.S. House Trading
No House trades found for BTMD.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.